NAM
AGN

Nissay Asset Management’s Allergan plc AGN Stock Holding History

Nissay Asset Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-40,160
Closed -$7.11M – 761
2020
Q1 		$7.11M Buy
40,160
+824
+2% +$155K 0.18% 125
2019
Q4 		$7.52M Sell
39,336
-3,775
-9% -$681K 0.17% 146
2019
Q3 		$7.25M Buy
43,111
+1,210
+3% +$197K 0.18% 139
2019
Q2 		$7.01M Sell
41,901
-1,340
-3% -$186K 0.18% 135
2019
Q1 		$6.33M Sell
43,241
-187
-0.4% -$27.1K 0.17% 151
2018
Q4 		$5.8M Sell
43,428
-656
-1% -$108K 0.18% 137
2018
Q3 		$8.4M Buy
44,084
+1,410
+3% +$259K 0.23% 109
2018
Q2 		$7.12M Buy
42,674
+1,334
+3% +$214K 0.21% 122
2018
Q1 		$6.96M Buy
41,340
+23
+0.1% +$3.86K 0.22% 112
2017
Q4 		$6.76M Buy
+41,317
New +$7.41M 0.21% 122

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Nissay Asset Management's AGN Position: Q2 2020 in Review

Nissay Asset Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 40,160 shares — an estimated $7.11M sold.

Nissay Asset Management first reported a position in AGN in Q4 2017 and held it in 10 quarters. The position peaked at $8.4M in Q3 2018. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Nissay Asset Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Nissay Asset Management sold 40,160 Allergan plc shares in Q2 2020, an estimated $7.11M.
  • Nissay Asset Management first reported a position in Allergan plc in Q4 2017 and held it in 10 quarters.
  • Nissay Asset Management's Allergan plc position peaked at $8.4M in Q3 2018.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Nissay Asset Management's 13F filing for Q2 2020, filed 27 Jul 2020.